Related Experiment Video
Updated: Apr 14, 2026

07:04
Confocal Time Lapse Imaging as an Efficient Method for the Cytocompatibility Evaluation of Dental Composites
Published on: November 9, 2014
14.0K
Cell Viability Assay of Chitosan-Modified Glass Ionomer Restorative Cements
Riaan Mulder1, Suné Mulder-van Staden2, Annette Olivier3
1Department of Prosthodontics, University of the Western Cape, Bellville, Cape Town 7530, South Africa.
Journal of Functional Biomaterials
|December 24, 2025
Summary
Chitosan-modified glass ionomer cements (GICs) were tested for cytocompatibility with fibroblast cells. While some GICs maintained consistent cell viability, none showed improved biocompatibility, with two showing decreased viability over time.
Area of Science:
- Biomaterials Science
- Dental Materials
- Cell Biology
Background:
- Glass ionomer cements (GICs) are widely used dental restorative materials.
- Modifications to GICs, such as chitosan (CS) incorporation, are explored to enhance their properties.
- Evaluating the cytocompatibility of these modified materials is crucial for clinical application.
Purpose of the Study:
- To assess the cytocompatibility of chitosan-modified glass ionomer cement (GIC) diluents.
- To evaluate the impact of CS modification on the biocompatibility of different GIC materials.
- To determine the effect of exposure time on the cytocompatibility of CS-modified GICs.
Main Methods:
- Three commercial GIC materials (Fuji IX GP, Ketac Universal, Riva Self Cure) were modified with chitosan.
- Diluents were prepared by exposing GIC specimens to DMEM for 0-1, 1-7, and 7-21 days.
- Cytocompatibility was assessed using a Balb/c 3T3 fibroblast cell line via indirect contact and SEM evaluation.
Main Results:
- Ketac Universal showed decreased cell viability on day 1.
- Fuji IX and CS-modified GICs demonstrated consistent cell viability.
- No CS-modified GICs exhibited enhanced cumulative cell biocompatibility; Riva Self Cure with CS showed reduced viability at day 21.
Conclusions:
- Chitosan modification did not universally improve the cytocompatibility of the tested GICs.
- Riva Self Cure modified with chitosan showed decreased fibroblast viability over a 21-day period.
- Further research is needed to optimize CS-GIC formulations for enhanced biocompatibility.

